supraventricular arrhythmias ira r. friedlander, m.d. 8/26/14

41
Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Upload: bartholomew-tyler-lang

Post on 11-Jan-2016

219 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Supraventricular Arrhythmias

Ira R. Friedlander, M.D.

8/26/14

Page 2: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Definition

• Rapid heart rhythm during which the electrical impulse propagates down the normal His Purkinje system similar to normal sinus rhythm

• Distinct from ventricular tachycardia which only originates in the ventricles

Page 3: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Mechanisms of Arrhythmia

• Automaticity– Enhanced automaticity – Abnormal automaticity

Page 4: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Mechanisms of Arrhythmia

• Triggered Activity– Small depolarizations during or just after

repolarization (phases 3 or 4) which can trigger a new depolarization.

Page 5: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Mechanisms of Arrhythmia

• Reentry-most common mechanism– Short circuit that forms between two

“pathways” that are either anatomically or functionally distinct

– Typically:• Path 1: Slow conduction, short refractory period• Path 2: Rapid conduction, long refractory

period

Page 6: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Reentry

Panel A: Most impulses conduct down both pathways.

Panel B: Unidirectional block, due to longer refractoriness in one pathway.

Panel C: Potential to have reentry back up the previously refractory pathway

Panel D: Reentry then can persist.

Page 7: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Supraventricular Arrhythmias

• Atrial arrhythmias (AT, AFL and AF)• Atrioventricular nodal reentrant tachycardia

(AVNRT) and junctional ectopic tachycardia (JET)

• Atrioventricular reentrant tachycardia (AVRT)Wolf-Parkinson-White Syndrome– Orthodromic AVRT– Antidromic AVRT

Page 8: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

SVT: Symptoms

• May be variable– Palpitations, chest pounding, neck pounding– Weakness/malaise– Dyspnea– Chest pain– Lightheadedness– Near syncope/syncope

• Symptoms usually abrupt in onset and termination• May have history of symptoms since childhood or

have a positive FHx

Page 9: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

SVT: Physical Exam

• In absence of tachycardia, usually normal

• Rapid heart rate (150-250)– May be irregular or regular (mechanism)

• BP may be low or with narrow pulse pressure

• Neck veins may reveal cannon waves.

Page 10: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Sinus Rhythm

• Originates in sinus node (automaticity)

• 50-100 bpm resting• Up to 200 bpm• Conduction through

normal AV axis• P wave morphology

reflects site of onset

Page 11: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial Tachycardia

• Ectopic atrial focus– Reentrant, automatic or

triggered

• 150-250 bpm• 1:1 AV conduction• Paroxysmal or “warm up”• P wave morphology

variable

Page 12: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Focal Atrial TachycardiaFocal Atrial Tachycardia

CSOCSO

IVCIVC

RAFWRAFW

RAARAA LAALAA

LAFWLAFW

PVPV

SNSN

IIA A SS

CTCT

* * ** * *

SVCSVC

Page 13: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

20 yr woman with post-partum congestive heart failure20 yr woman with post-partum congestive heart failure

I

II

III

aVR

aVL

aVF

V1

V2

V3

V4

V5

V6

Page 14: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Adenosine InjectionAdenosine Injection

III

IIIaVRaVL

aVF

V1

V2

V3

V4

V5V6

Page 15: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

I

II

IIIaVR

aVL

aVF

V1

V2

V3

V4

V5V6

Post- Adenosine InjectionPost- Adenosine Injection

Page 16: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Catheter location : Right atrial Catheter location : Right atrial appendageappendage

RAORAO LAOLAO

CT MAP

CS

His

CTMAP

CS

His

Page 17: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

IIIII

aVL

I

MAP dist

MAP prox

CT 1,2

CT 5,6

CT 9,10

CT 15,16

CT 3,4

CT 7,8

CT 13,14

CS dist

CS prox

CT 11,12

Earliest Atrial Activation : Right Atrial AppendageEarliest Atrial Activation : Right Atrial Appendage

- 23 msec

Page 18: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

IIIII

aVL

I

MAP distMAP prox

CT 1,2

CT 5,6

CT 9,10

CT 15,16

CT 3,4

CT 7,8

CT 13,14

CS distCS prox

CT 11,12

CT 17,18

CT 19,20

Sinus RhythmSinus RhythmAtrial TachycardiaAtrial Tachycardia

RF on 1.9 sec

Page 19: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial Flutter

• Reentrant circuit localized to the RA

• 250-350 bpm

• 2:1 or variable AV block

• Classic “saw-tooth” P waves

Page 20: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Activation on Halo Catheter Activation on Halo Catheter

II

aVF

V1

CS Os

TA 1,2

TA 3,4TA 5,6

TA 7,8

TA 9,10

TA 11,12

TA 13,14

TA 17,18TA 19,20

Typical = CounterclockwiseTypical = Counterclockwise

TA 19,20

CS Os

TA 9,10

TA 1,2

Page 21: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Activation on Halo Catheter Activation on Halo Catheter

Atypical = ClockwiseAtypical = Clockwise

II

aVF

V1

CS Os

TA 1,2

TA 3,4TA 5,6

TA 7,8

TA 9,10

TA 11,12

TA 13,14

TA 17,18 19,20

TA 19,20

CS Os

TA 9,10

TA 1,2

Page 22: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial Fibrillation

• Chaotic atrial rhythm due to multiple reentrant wavelets

• 350-500 bpm• Ventricular rate irregular

and rapid due to variable AV block

• HTN, valvular dz., metabolic dz., CMP, EtOH

Page 23: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial Fibrillation

• The rapid atrial activity results in: – Increased risk of thrombus formation and stroke– Rapid and irregular ventricular rate

• The treatment is aimed at:– Decreasing the risk of stroke (coumadin, ASA)– Decreasing the ventricular rate (beta-blockers,

calcium channel blockers, digoxin)– Restoring the rhythm to sinus (drug therapy,

catheter ablation, surgical Maze)

Page 24: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial Fibrillation

• Advantages of rhythm control: – Abolition of symptoms– Halting atrial enlargement– Improvement in left ventricular function and

exercise capacity

• Disadvantages of rhythm control:– Subjecting patients to drug therapy and/or

procedure that might be associated with complications

Page 25: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial FibrillationTreatment

• In patients with minimal symptoms and normal left ventricular function: – Coumadin/ASA– Rate control (drugs, AVJ ablation + BV pacing)

• In patients with significant symptoms and/or left ventricular dysfunction:– Coumadin/ASA– Rate control (drugs, AVJ ablation + BV pacing)– Rhythm control (anti-arrhytmic drugs, catheter ablation)

Page 26: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Drug Therapy to Maintain Sinus Rhythm in Patients with Recurrent Paroxysmal or Persistent Atrial Fibrillation

ACC/AHA/ESC Guidelines

Page 27: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial FibrillationCatheter Ablation

Ablate PV potentials PV Isolation Pappone (circumferential LA ablation)

Page 28: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

AV Nodal Reentrant Tachycardia

Morphology and location of P wave relative to QRS distinct

Page 29: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

27 y.o with palpitations

Page 30: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Pseudo R’ in V1 during tachycardia

NSR AVNRT

Page 31: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Junctional Ectopic Tachycardia

Page 32: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Normal sinus rhythm

Junctional tachycardia

Page 33: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Wolff-Parkinson-White Syndrome

• Second electrical connection exists between the atria and ventricles (accessory pathway)– Resemble atrial tissue

– Results in a short PR and

– Delta wave (pre-excitation)

• Some AP conducts only retrograde (concealed)

Page 34: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Arrythmias in WPW

• The most common arrhythmia is orthodromic AV reentrant tachycardia (narrow QRS)

• Less common are pre-excited tachcyardias (wide QRS)– Antidromic AV reentrant tachycardia – Atrial tachycardia/flutter with pre-excitation– AVNRT with pre-excitation– Atrial fibrillation with pre-excitation (most life

threatening due to rapid ventricular response)

Page 35: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Orthodromic AVRT

Conduction down AV axis during tachycardia gives NARROW QRS complex

Page 36: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Pre-excited Tachycardia Mechanisms

AVRT AT

AVNRT

Conduction down AP during tachycardia gives WIDE QRS complex

Page 37: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Atrial Fibrillation

Page 38: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

RF Ablation in WPW

Page 39: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

SUMMARYMechanisms of SVT

Atrial Tachycardia AVNRT AVRT

FPSP

Page 40: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

Differential Diagnosis of NCT

• Short RP– AVRT– AT– Slow-Slow

AVNRT

• Long RP– AT– Atypical

AVNRT– PJRT

• P buried in QRS– Typical AVNRT– AT– JET

Page 41: Supraventricular Arrhythmias Ira R. Friedlander, M.D. 8/26/14

SUMMARY

• Obtain a 12 lead ECG. The location of the P wave will dictate the differential diagnosis

• If hemodynamically unstable (chest pain, heart failure, hypotension) CARDIOVERSION

• If hemodynamically stable AV NODAL AGENT• Long term therapy depends on mechanism and can

be conservative, pharmacologic or invasive • EP study often needed for definitive characterization

of mechanism and can cure most SVTs with 90% success rate